|
Originally published In Press as doi:10.1074/jbc.M111679200 on January 15, 2002
J. Biol. Chem., Vol. 277, Issue 13, 11292-11296, March 29, 2002
Identification of a Common Sphingolipid-binding Domain in
Alzheimer, Prion, and HIV-1 Proteins*
Radhia
Mahfoud,
Nicolas
Garmy,
Marc
Maresca,
Nouara
Yahi,
Antoine
Puigserver, and
Jacques
Fantini
From the Institut Méditerranéen de Recherche en
Nutrition, Unité Mixte de Recherche-Institut National de
la recherche Agronomique 1111, Faculté des Sciences
St-Jérôme, 13397 Marseille Cedex 20, France
The V3 loop of the human immunodeficiency virus
(HIV)-1 surface envelope glycoprotein gp120 is a sphingolipid-binding
domain mediating the attachment of HIV-1 to plasma membrane
microdomains (rafts). Sphingolipid-induced conformational changes in
gp120 are required for HIV-1 fusion. Galactosylceramide and
sphingomyelin have been detected in highly purified preparations of
prion rods, suggesting that the prion protein (PrP) may interact with
selected sphingolipids. Moreover, a major conformational transition of the Alzheimer -amyloid peptide has been observed upon
interaction with sphingolipid-containing membranes. Structure
similarity searches with the combinatorial extension method
revealed the presence of a V3-like domain in the human prion protein
PrP and in the Alzheimer -amyloid peptide. In each case, synthetic
peptides derived from the predicted V3-like domain were found to
interact with monomolecular films of galactosylceramide and
sphingomyelin at the air-water interface. The V3-like domain of PrP is
a disulfide-linked loop (Cys179-Cys214)
that includes the E200K mutation site associated with familial Creutzfeldt-Jakob disease. This mutation abrogated sphingomyelin recognition. The identification of a common sphingolipid-binding motif
in gp120, PrP, and -amyloid peptide underscores the role of lipid
rafts in the pathogenesis of HIV-1, Alzheimer, and prion diseases and
may provide new therapeutic strategies.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 33-491-288-761;
Fax: 33-491-288-440; E-mail: jacques.fantini@univ.u-3mrs.fr.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Lund, M. L. Olsson, S. Ramkumar, D. Sakac, V. Yahalom, C. Levene, A. Hellberg, X.-Z. Ma, B. Binnington, D. Jung, et al.
The human Pk histo-blood group antigen provides protection against HIV-1 infection
Blood,
May 14, 2009;
113(20):
4980 - 4991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ramkumar, D. Sakac, B. Binnington, D. R Branch, and C. A Lingwood
Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels
Glycobiology,
January 1, 2009;
19(1):
76 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Saslowsky, N. Tanaka, K. P. Reddy, and W. I. Lencer
Ceramide activates JNK to inhibit a cAMP-gated K+ conductance and Cl- secretion in intestinal epithelia
FASEB J,
January 1, 2009;
23(1):
259 - 270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Bakrac, I. Gutierrez-Aguirre, Z. Podlesek, A. F.-P. Sonnen, R. J. C. Gilbert, P. Macek, J. H. Lakey, and G. Anderluh
Molecular Determinants of Sphingomyelin Specificity of a Eukaryotic Pore-forming Toxin
J. Biol. Chem.,
July 4, 2008;
283(27):
18665 - 18677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hebbar, E. Lee, M. Manna, S. Steinert, G. S. Kumar, M. Wenk, T. Wohland, and R. Kraut
A fluorescent sphingolipid binding domain peptide probe interacts with sphingolipids and cholesterol-dependent raft domains
J. Lipid Res.,
May 1, 2008;
49(5):
1077 - 1089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Prior, S. Lehmann, M.-S. Sy, B. Molloy, and H. E. M. McMahon
Cyclodextrins Inhibit Replication of Scrapie Prion Protein in Cell Culture
J. Virol.,
October 15, 2007;
81(20):
11195 - 11207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Race, J. H. Lakey, and M. J. Banfield
Insertion of the Enteropathogenic Escherichia coli Tir Virulence Protein into Membranes in Vitro
J. Biol. Chem.,
March 24, 2006;
281(12):
7842 - 7849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Sepulveda, M. Berrocal-Carrillo, M. Gasset, and A. M. Mata
The Plasma Membrane Ca2+-ATPase Isoform 4 Is Localized in Lipid Rafts of Cerebellum Synaptic Plasma Membranes
J. Biol. Chem.,
January 6, 2006;
281(1):
447 - 453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. A. Openshaw, P. R. Race, H. J. Monzo, J.-A. Vazquez-Boland, and M. J. Banfield
Crystal Structure of SmcL, a Bacterial Neutral Sphingomyelinase C from Listeria
J. Biol. Chem.,
October 14, 2005;
280(41):
35011 - 35017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Avota, N. Muller, M. Klett, and S. Schneider-Schaulies
Measles Virus Interacts with and Alters Signal Transduction in T-Cell Lipid Rafts
J. Virol.,
September 1, 2004;
78(17):
9552 - 9559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sarnataro, V. Campana, S. Paladino, M. Stornaiuolo, L. Nitsch, and C. Zurzolo
PrPC Association with Lipid Rafts in the Early Secretory Pathway Stabilizes Its Cellular Conformation
Mol. Biol. Cell,
September 1, 2004;
15(9):
4031 - 4042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Walmsley, F. Zeng, and N. M. Hooper
The N-terminal Region of the Prion Protein Ectodomain Contains a Lipid Raft Targeting Determinant
J. Biol. Chem.,
September 26, 2003;
278(39):
37241 - 37248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Baron and B. Caughey
Effect of Glycosylphosphatidylinositol Anchor-dependent and -independent Prion Protein Association with Model Raft Membranes on Conversion to the Protease-resistant Isoform
J. Biol. Chem.,
April 18, 2003;
278(17):
14883 - 14892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yamabhai and R. G. W. Anderson
Second Cysteine-rich Region of Epidermal Growth Factor Receptor Contains Targeting Information for Caveolae/Rafts
J. Biol. Chem.,
July 5, 2002;
277(28):
24843 - 24846.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|